Well Run profileThe Chase Pack · #509 of 720

Position 509

Octave

In-network therapy practice plus WiseMatch, a tool that lets health plans match and book therapists

Pace
5:20/kmSteady2.25
Distance
Distance 10K.
Open ops roles
3
Last week
#441
Move
▼ 68
Peak
#441
Weeks in the 100
0
The Chart →
Rank and score over time
Board rank
#431#467#503#441Oct 18#493Oct 25
Pace score
02462.3Oct 182.3Oct 25

One point per Sunday re-rank, tracking since Oct 18. The lines fill in week by week.

Octave runs in the Steady lane (5:20/km): 143 of 196. Further right = more momentum. No competitors on the board yet, so it runs alone.
Total raised
$86M (as of Jun 2023)see rounds ↓
Founded
2018
HQ
San Francisco, CA

Leadership

The problem

People can't find an in-network therapist who is good, available and a fit; insurer directories are full of ghost listings

What they do

In-network therapy practice plus WiseMatch, a tool that lets health plans match and book therapists

Traction Therapy in 23 states; WiseMatch used across 100,000+ providers and plans covering 23M+ lives

Hiring trend

Open roles
16
Ops roles
3
Headcount
~420-630

Headcount ~626 on LinkedIn, +9% YoY; 16 open roles (10 are 1099 clinician postings)

Funding

Last round
$12.7M
Stage
Series C
Date
Nov 2025

Led by Undisclosed (PitchBook mezzanine); Series C ($52M, Jun 2023) led by Cigna Ventures, Novo Holdings, Avidity Partners

Distance

10K · edge: grows with users

A mid-size in-network therapy practice well behind Headway, Alma, Grow Therapy and Rula, which it now partners with for WiseMatch; the payer-directory tool is a promising second line but early, and the last priced round was 2023.

Sources: Business Wire: Octave debuts WiseMatch with Grow Therapy, Rula, SonderMind (Mar 2026) ↗ · Business Wire: WiseMatch Index, 100,000+ providers, 23M+ covered lives (Sep 2026) ↗

Last checked Oct 25, 2026

Funding historyTotal raised $86M (as of Jun 2023)

  1. Jun 2023Series C$52MLed by Cigna Ventures, Novo Holdings, Avidity Partners prnewswire.com ↗
  2. May 2021Series B$20MLed by Health Velocity Capital findoctave.com ↗
  3. Oct 2019Series A$11MLed by Greycroft news.crunchbase.com ↗
  4. Apr 2018Seed$3MLed by Felicis Ventures news.crunchbase.com ↗

Profile facts checked Oct 19, 2026. Every fact links to its public source.

Keep going

← Back to the board